---
title: "SMITH BRANDON D — Ownership Dossier"
canonical: https://whiteintel.dev/entity/f6a40b60-de11-57a2-a437-d0da91cd4b5b
json: https://whiteintel.dev/api/public/dossier/f6a40b60-de11-57a2-a437-d0da91cd4b5b
identifier: sec:0002005266
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# SMITH BRANDON D

**Type:** Company  
**Jurisdiction:** US  
**Identifier:** `sec:0002005266`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/f6a40b60-de11-57a2-a437-d0da91cd4b5b  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/f6a40b60-de11-57a2-a437-d0da91cd4b5b  

## Ownership & control

### Holdings / subsidiaries

- **IMPEL NEUROPHARMA INC** (officer) — https://whiteintel.dev/entity/32a51ecc-2194-5141-922b-0b01ac58d5f7

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **SMITH BRANDON D**. Human view: https://whiteintel.dev/entity/f6a40b60-de11-57a2-a437-d0da91cd4b5b · Structured JSON: https://whiteintel.dev/api/public/dossier/f6a40b60-de11-57a2-a437-d0da91cd4b5b._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._